Elena Ridloff Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Elena Ridloff is of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2025, when has been sold 4,500 shares (Common Stock) at a price of $50.0 per share, resulting in proceeds of $225,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Elena Ridloff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
SELL
Open market or private sale
$225,000 $50.0 p/Share
4,500 Reduced 100.0%
0 Common Stock
Jun 11 2025
BUY
Exercise of conversion of derivative security
$91,305 $20.29 p/Share
4,500 Added 50.0%
4,500 Common Stock
Jun 03 2025
SELL
Open market or private sale
$555,000 $46.25 p/Share
12,000 Reduced 100.0%
0 Common Stock
Jun 03 2025
BUY
Exercise of conversion of derivative security
$332,040 $27.67 p/Share
12,000 Added 50.0%
12,000 Common Stock

Also insider at

KRON
Kronos Bio, Inc. Healthcare
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
EVP and CFO
SION
Sionna Therapeutics, Inc.
CFO & Head of Corp. Dev.
ER

Elena Ridloff

San Diego, CA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR